Latest: FDA Approves New Biosimilar for Oncology Treatment

Navigating the Evolving Second-Line Landscape of Metastatic Urothelial Carcinoma

by Cancer Network

13 September, 2025

0 Mins

The latest in first- and second-line therapies for bladder cancer, including trial data, AE management, and the role of molecular testing, were discussed in the latest Oncology Decoded podcast.

Tags:

Author

Cancer Network

2 Minute Medicine: Pharma Roundup – Landmark lung approval, billion-dollar obesity drug deal, oncology safety halt, and GSK’s China push [August 14 2025]

Award-winning cancer research: from A to TME

📢

300x250 Banner

Navigating the Evolving Second-Line Landscape of Metastatic Urothelial Carcinoma

Tags:

Cancer Network

2 Minute Medicine: Pharma Roundup – Landmark lung approval, billion-dollar obesity drug deal, oncology safety halt, and GSK’s China push [August 14 2025]

Award-winning cancer research: from A to TME

Recent Content

COPD Biologics: Early Treatment Insights

Antihypertensive Medication Guidelines

Juvenile Arthritis Care Transition